Physician profile
Brian M Pellini
NPI 1972632198
$1,172.82
in general payments reported to CMS, 2019-2025
19 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $58.83 · 2021: $119 · 2023: $246 · 2024: $95.85 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $655.66 | 2019-2023 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $63.48 | 2021-2025 | Stravix, Stravix Pl, Grafix Pl |
| Tela Bio, INC. | $56.45 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Astellas Pharma US INC | $51.08 | 2024-2025 | Vyloy |
| Bioventus LLC | $49.53 | 2023 | |
| Davol INC. | $38.47 | 2020-2023 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $35.27 | 2025 | Keytruda |
| Takeda Pharmaceuticals U.S.A., INC. | $25.16 | 2025 | Ninlaro |
| Shockwave Medical, INC | $24.61 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $23.32 | 2019 | |
| Mozarc Medical US LLC | $21.10 | 2024 | Argyle |
| Stemline Therapeutics INC. | $20.29 | 2025 | Orserdu |
| Medtronic, INC. | $17.44 | 2025 | Biosyn |
| Innocoll Pharmaceuticals Limited | $17.33 | 2021 | |
| Karyopharm Therapeutics INC. | $16.56 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $15.95 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.55 | 2024 | Calquence |
| Kci USA, INC. | $14.40 | 2020 | |
| Karl Storz Endoscopy-America | $11.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Pellini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.